Go to the list of all blogs
Anna G's Avatar
published in Blogs
Jul 08, 2022
TickeronGET DAILY SIGNALS
RVL Pharmaceuticals (RVLP, $1.49) reports Q2 preliminary Upneeq sales of $8.4 million

RVL Pharmaceuticals (RVLP, $1.49) reports Q2 preliminary Upneeq sales of $8.4 million

RVL Pharmaceuticals plc. announced its preliminary second quarter  FY22 sales from Upneeq of $8.4 million. The figure represents a +42% growth sequentially.

Upneeq is an approved ophthalmic solution for droopy eyelids.

The company also mentioned that it had received orders from approximately 2,200 cumulative unique medical aesthetics practices from February through June of 2022.

CEO Brian Markison said, “ As planned and previously announced, we expect to significantly expand our medical aesthetics salesforce by mid to late July and believe that we are well-positioned to build on our momentum and achieve our fourth quarter 2022 net sales projection."

RVL reaffirmed its outlook on Q4 Upneeq sales in the range of $20 million to $25 million.

Related Ticker: RVLP
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RVLP
A.I. Advisor
published General Information

General Information

a manufacturer of generic pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
400 Crossing Boulevard
Phone
+1 908 809-1300
Employees
125
Web
https://www.rvlpharma.com
Interact to see
Advertisement

Energy Recovery Inc. (ERII) Stock Analysis: Capitalizing on Rising Desalination Demand

ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
ERII#IndustrialSpecialties
Abhoy Sarkar, expert
Feb 20, 2026

Liberty Broadband Corporation (LBRDA) Stock Analysis: Volatility Builds Around Charter Merger

Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
LBRDA#MajorTelecommunications
Abhoy Sarkar, expert
Feb 21, 2026

Arm Holdings (ARM) Stock Analysis: AI Expansion Redefines the Growth Narrative

Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Dem Sem, expert
Feb 21, 2026

Shell plc (SHEL) Stock Analysis: Balancing Shareholder Returns and Energy Transition

Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
SHEL#IntegratedOil
Dem Sem, expert
Feb 24, 2026

Linde plc (LIN) Stock Analysis: Strong Execution Meets Conservative Outlook

Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
LIN#ChemicalsSpecialty
Dem Sem, expert
Feb 26, 2026

ConocoPhillips (COP) Stock Analysis: Efficiency Push Amid Earnings Headwinds

ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
COP#OilGasProduction
Dem Sem, expert
Feb 26, 2026

BAH vs. VRSK Stock Comparison: Earnings Recap, Results, and Forward Guidance

Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
BAHVRSK#DataProcessingServices
Arthur Evans, expert
Feb 26, 2026

Omnicom Group (OMC) Q4 2025 Earnings Recap: IPG Acquisition Drives Revenue Jump

(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
OMC#AdvertisingMarketingServices
Arthur Evans, expert
Feb 26, 2026

CPRT vs. GPN vs. TRI: Earnings Preview and Recent Performance Review

Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
CPRTGPNTRI#OfficeEquipmentSupplies
Arthur Evans, expert
Feb 20, 2026

DEO vs. KDP vs. UL: Which Consumer Staples Stock Would AI Prefer?

Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
DEOKDPUL#HouseholdPersonalCare#BeveragesAlcoholic#BeveragesNonAlcoholic
Arthur Evans, expert
Feb 21, 2026

Blue Bird Corporation (BLBD) Stock Analysis: EV Momentum and Strategic Expansion

Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
BLBD#TrucksConstructionFarmMachinery
Arthur Evans, expert
Feb 21, 2026

Why IBM Just Plunged 10%: The AI Shock Wall Street Didn’t See Coming

IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
IBM#InformationTechnologyServices
Feb 23, 2026

Novo Nordisk (NVO) Plunges 16% After Obesity Drug Misses Against Lilly

Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
NVOLLY#PharmaceuticalsMajor
Feb 23, 2026

Why RingCentral Crashed (RNG) 12% After Soaring 40%: The Hangover After the Hype

RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
RNG#PackagedSoftware
Feb 23, 2026

BLLN’s Breakout Just Broke Down: Inside Today’s 15% Slide

Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
BLLN#MedicalSpecialties
Alicia, beginner
Feb 23, 2026

Why Tennant (TNC) Crashed -25%: When an ERP Rollout Goes Off the Rails

TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
TNC#IndustrialMachinery
Alicia, beginner
Feb 24, 2026

From Record Results to a -21% Rout: What Really Hit Xometry (XMTR) Today

XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
XMTR#ElectronicsDistributors
Alicia, beginner
Feb 24, 2026

Penny Stock Physics: How EDSA Jumped +20% on Thin Air

EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
EDSA#Biotechnology
Alicia, beginner
Feb 24, 2026

Why CECO Environmental Corp (CECO) Crashed -22% on ‘Record’ Results: When Earnings Misses Meet a Risky Mega‑Deal

Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
CECO#IndustrialSpecialties
Feb 24, 2026

Which Stock Would AI Choose? Estée Lauder (EL) vs. Kimberly-Clark (KMB) vs. Constellation Brands (STZ)

Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
KMBSTZEL#HouseholdPersonalCare#FoodMeatFishDairy
Dem Sem, expert
Feb 26, 2026